- Home
- BMR vs IMMX Comparison
BMR vs IMMX Comparison
Compare BMR & IMMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- IMMX
- Stock Information
- Founded
- BMR 2009
- IMMX 2014
- Country
- BMR Israel
- IMMX United States
- Employees
- BMR N/A
- IMMX N/A
- Industry
- BMR Computer Software: Prepackaged Software
- IMMX Medicinal Chemicals and Botanical Products
- Sector
- BMR Technology
- IMMX Health Care
- Exchange
- BMR Nasdaq
- IMMX Nasdaq
- Market Cap
- BMR 59.3M
- IMMX 61.1M
- IPO Year
- BMR 2023
- IMMX 2021
- Fundamental
- Price
- BMR $3.19
- IMMX $2.35
- Analyst Decision
- BMR
- IMMX Strong Buy
- Analyst Count
- BMR 0
- IMMX 1
- Target Price
- BMR N/A
- IMMX $7.00
- AVG Volume (30 Days)
- BMR 1.0M
- IMMX 540.4K
- Earning Date
- BMR 08-05-2025
- IMMX 08-11-2025
- Dividend Yield
- BMR N/A
- IMMX N/A
- EPS Growth
- BMR N/A
- IMMX N/A
- EPS
- BMR N/A
- IMMX N/A
- Revenue
- BMR $3,064,000.00
- IMMX N/A
- Revenue This Year
- BMR $21.21
- IMMX N/A
- Revenue Next Year
- BMR N/A
- IMMX N/A
- P/E Ratio
- BMR N/A
- IMMX N/A
- Revenue Growth
- BMR 5.33
- IMMX N/A
- 52 Week Low
- BMR $1.86
- IMMX $1.26
- 52 Week High
- BMR $6.59
- IMMX $3.00
- Technical
- Relative Strength Index (RSI)
- BMR 51.92
- IMMX 54.87
- Support Level
- BMR $2.88
- IMMX $2.20
- Resistance Level
- BMR $4.32
- IMMX $2.46
- Average True Range (ATR)
- BMR 0.31
- IMMX 0.27
- MACD
- BMR -0.04
- IMMX -0.01
- Stochastic Oscillator
- BMR 20.19
- IMMX 44.39
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.